Latest news
03.04.2020
Issuance of a 2nd tranch of €1 million of notes convertible into new shares
DEINOVE immediately strengthens its cash position by €1 million DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses...
01.04.2020
DEINOVE obtains from Société Générale Factoring the pre-funding of its 2019 R&D Tax Credit receivable amounting to EUR 2.1 million
For the second year in a row, DEINOVE has called on Société Générale Factoring (SGF) to pre-finance its R&D Tax Credit receivable...
30.03.2020
In a climate of economic and industrial uncertainty, the collaboration agreement between Sharon Laboratories and Deinove will not be signed
The current health, economic and financial crisis creates too much uncertainty to enter into a long-term full partnership around a complete...
Press Coverage
19.06.2019
DEINOVE among The Top 20 Industrial Biotechnology Companies in Europe
Europe’s industrial biotechnology sector is driving a massive change from petrochemical processes to more sustainable alternatives. Here...
14.06.2019
Formule Verte | Deinove et Avril avancent sur leur nouvelle gamme d’ingrédients
La société de biotechnologies industrielles Deinove et Avril, l’acteur industriel et financier des filières des huiles et des protéines,...
05.06.2019
Zone Bourse | DEINOVE : LCM confirme sa recommandation d'Achat
LCM a confirmé sa recommandation d'Achat et son objectif de cours de 2,7 euros sur Deinove après la signature d'un partenariat avec Dow...